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Abstract 
Objectives: The microbial composition of peri-implantitis-associated biofilms may 
resemble that of periodontitis, with some distinctive differences, as identified by 
various conventional or molecular detection methods. Yet, the complete microbiome 
of peri-implantitis awaits further characterization. The present clinical study was 
undertaken with the aim to investigate the association of Spirochaetes, and the more 
recently identified phylum Synergistetes, with peri-implantitis. Materials and 
Methods: Submucosal biofilms were obtained from single sites of patients with peri-
implantitis (n=43) or individuals with peri-implant health (n=41). The samples were 
analyzed by fluorescnce in situ hybridisation (FISH) and epifluorescence microscopy, 
using 16S rRNA-based oligonucleotide probes for Synergistetes cluster A, sub-
clusters A1 and A2, and Treponema groups I-III and IV. Results: Treponema group 
IV was barely detectable, whereas Treponema groups I-III were detected at low 
prevalence in health, but their prevalence and numbers were significantly increased in 
peri-implantitis by 48% and 2.4-log, respectively. Synergistetes cluster A was 
detected in half of the healthy sites, and its prevalence and numbers were significantly 
increased in peri-implantitis by 30% and 2.5-log, respectively. No quantitative 
differences were found between Synergistetes sub-clusters A1 and A2 numbers, as 
both increased by 2.8-log. Synergistetes cluster A displayed strong correlations with 
several clinical peri-implant parameters, but Treponema groups I-III only with 
probing pocket depth. Conclusion: The present clinical cross-sectional study 
demonstrates that Spriochaetes of the Treponema groups I-III, but not group IV, and 
Synergistetes of the cluster A are highly associated with peri-implantitis. Synergistetes 
cluster A appears to display a stronger association with peri-implantitis than 
Spirochaetes. 
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Introduction 
Although it is well established that the microbiological features of peri-implantitis 
closely resemble those of periodontitis (Mombelli & Decaillet 2011), novel molecular 
microbiological methods are shedding light to some distinctive differences between 
the two disease forms (Belibasakis 2014, Belibasakis, et al. 2015, Charalampakis & 
Belibasakis 2015, Dabdoub, et al. 2013, Faveri, et al. 2015, Kumar, et al. 2012). 
Historically, the lack of appropriate protocols to cultivate and characterize at least half 
of the oral taxa has also hampered our understanding of the microbiota associated 
with peri-implantitis. Yet, with the use of molecular detection methods, we are 
becoming increasingly able in bridging this knowledge gap. Among such is the 16S 
rRNA-based fluorescence in situ hybridisation (FISH), which utilizes epifluorescence 
microscopy to identify non-cultivable taxa at the genus or species level (Gmur, et al. 
2000, Wecke, et al. 2000). This approach has been successfully used in the 
characterization of the periodontitis-associated residing in subgingival biofilms 
(Ammann, et al. 2013, Drescher, et al. 2010, Vartoukian, et al. 2009, Zijnge, et al. 
2010). 
Among the largely uncultivable taxa to this date are Spirochaetes and 
Synergistetes, which are two of the 13 different phyla identified in the Human Oral 
Microbiome Database (HOMD) (Dewhirst, et al. 2010). A large proportion of 
Spirochaetes belong to the genus Treponema. Treponemes are unicellular Gram-
negative spiral-shaped anaerobic rods of varying length. There is a well-established 
association between their presence in subgingival biofilms and chronic or aggressive 
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periodontitis (Dewhirst, et al. 2000, Haffajee, et al. 2006, Moter, et al. 1998), whereas 
there is also evidence of their involvement in peri-implantitis (Papaioannou, et al. 
1995, Renvert, et al. 2007). 
The bacterial phylum Synergistetes consists of Gram-negative anaerobic 
curved rods. They can be found as part of the healthy oral microbiota (Horz, et al. 
2006, Vartoukian, et al. 2007), and their particular association with oral disease has 
been demonstrated in periodontitis (Belibasakis, et al. 2013, Vartoukian, et al. 2009, 
You, et al. 2013) necrotizing gingivitis (Baumgartner, et al. 2012) and endodontic 
infections (Fernandes Cdo, et al. 2014). To date, the human oral Synergistetes are 
divided principally in clusters A and B (Vartoukian, et al. 2009), with cluster A being 
more associated with oral disease than cluster B (Belibasakis 2014, You, et al. 2013), 
and exhibiting phylogenetically a more distinctive division in sub-clusters A1 and A2 
(Baumgartner, et al. 2012). 
While there is increasing evidence of the presence of Spirochaetes in peri-
implantitis (Koyanagi, et al. 2013, Zhuang, et al. 2014), the presence of Synergistetes 
in the disease has barely been studied (Koyanagi, et al. 2010, Maruyama, et al. 2014). 
Therefore, by using FISH in combination with epifluorescence microscopy, the 
primary aim of this clinical study was to evaluate prevalence and numbers of known 
human oral Synergistetes and Spirochetes in submucosal biofilm of patients with peri-
implantitis or individuals with peri-implant health. A further aim was to investigate 
the association between the levels of these taxa and clinical parameters of the severity 
of peri-implant disease. It is hypothesized that higher levels of Synergistetes and 
Spirochaetes will be identified in submucosal biofilm samples of patients with peri-
implantitis, than individuals with peri-implant health. 
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Materials and Methods 
Patient recruitment 
This study was approved by the Ethical Review Committee of the Canton of Zürich, 
Switzerland (KEK-Nr: 2011-0159), and was conducted in accordance with the 
guidelines of the world Medical Association Declaration of Helsinki. Patients were 
recruited as outpatients who were referred by private practitioners for the diagnosis 
and treatment of peri-implant health associated problems at the Interdisciplinary Peri-
implantitis Unit, Center of Dental Medicine at the University of Zürich. Potential 
participants were informed about the voluntariness of their participation and aim of 
the study. Inclusion criteria involved good overall medical health as evidenced by the 
medical history, at least 18 years of age, and willingness to participate in the study. 
Criteria for exclusion were periodontal or peri-implant treatment within the past 12 
months, intake of systemic antibiotics within the past 6 months and pregnancy or 
lactation. The selection of patients was based on radiographic evaluation of the 
marginal bone level, clinical signs of inflammation and/or presence of pus. For 
inclusion into the peri-implantitis group, the intraoral radiographic examination 
demonstrated at least one implant with post-insertion radiographic marginal bone loss 
of 2.0 mm or greater mesially or distally, over a period of one year. The control group 
included implants with a healthy peri-implant status (absence of pus or 
visible/detectable radiographic bone loss), which were functionally loaded for at least 
one year. The demographic parameters of gender and age were recorded. Clinical 
parameters included diagnosis of peri-implantitis, implant age (time from 
installation), suppuration, radiographic bone loss, width of the keratinized mucosa, as 
well as plaque index (PI), bleeding on probing (BOP) and probing pocket depth 
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(PPD). The latter three parameters were measured at 6 sites per implant. All subjects 
provided written and informed consent for sample collection. 
 
Submucosal biofilm sample collection 
Submucosal biofilm samples were collected from sites of patients with either peri-
implantitis, or healthy peri-implant sites of healthy subjects. In cases with multiple 
implants, one single implant was randomly sampled per patient. The samples were 
taken from the mesio-vestibular pocket of the implant. For this, the supramucosal 
areas of the implant and supra-structure were isolated from cheek and tongue using 
cotton rolls, and air-dried. Supramucosal biofilm was carefully removed with a cotton 
pellet, and the submucosal biofilm samples were obtained with a Gracey curette 
(Deppeler, Rolle, Switzerland). The biofilm sample collected by the first stroke was 
transferred to a micro-centrifuge tube containing 0.1 ml of RNAse-free TE buffer (10 
mM Tris-HCl, 1 mM EDTA, pH 7.6). The biofilm sample collected from the second 
to the fifth stroke was transferred to a another micro-centrifuge tube with 0.1 ml of 
0.9% NaCl containing 1:500 RNase Inhibitors (Sigma Aldrich, Buchs, Switzerland), 
and stored at –80°C until further use. This content of this latter tube was further 
processed for the microbiological analysis by FISH performed in this study, as 
detailed in the next section. 
 
Analysis biofilm samples by fluorescent in situ hybridization (FISH) 
The FISH analysis of the biofilm samples was performed according to previously 
described protocols (Baumgartner, et al. 2012). Briefly, after thawing, the samples 
were vortexed for 1 min and diluted 1:10 in coating buffer (0.9% NaCl, 0.02% NaN3, 
2.5 x 10-4 % hexadecyltrimethyammonium bromide). Ten µl of the suspensions were 
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then spotted on individual 18- or 24-well epoxy coated ADCELL multi-well slides, 
with a well-diameter of 4 mm (Cel-Line, Erie Scientific Company, Portsmouth, NH, 
USA). Following air-drying, the slides were fixed with 4% paraformaldehyde (PFA) 
at +4°C, for 20 min, and each well was there after covered by 9 µl of Denhardt’s 
solution (Fluka, Buchs, Switzerland; diluted 1:50 in PBS) with 1:500 Protect RNA 
RNase inhibitor (Sigma Aldrich, Buchs, Switzerland), and incubated at 37 °C, for 1 h. 
For the hybridization step, five specific oligonucleotide rRNA probes were used for 
Synergistetes cluster A (Fernandes Cdo, et al. 2014, Vartoukian, et al. 2009, Zijnge, et 
al. 2010), Synergistetes sub-cluster A1, Synergistetes sub-cluster A2 (Baumgartner, et 
al. 2012), Treponema cluster 1 (Zijnge, et al. 2010) covering multiple oral treponemes 
of the previously determined groups I-III (Choi, et al. 1996) (including Treponema 
denticola, Treponema vincentii, Treponema medium, Treponema parvum), and 
Treponema group IV (including Treponema lecithinolyticum and Treponema 
maltophilum) (Choi, et al. 1996, Guggenheim, et al. 2009) and one universal probe, 
which identifies most eubacteria (Amann, et al. 1995). The oligonucteotide sequences 
of the rRNA probes labelled with Cy3 or 6-FAM (Microsynth, Balgach, Switzerland), 
their targeted taxa, and the respective publications in which they were validated are 
listed in Table 1. The final probe concentrations used for FISH were 5 ng/µl for Cy3 
conjugates and 20 ng/µl for FAM conjugates, in the presence of 35% or 40% 
formamide. The FISH-stained samples were thereafter visualized by an Olympus 
BX60 fluorescence microscope (Olympus Optical, Volketswil, Switzerland). For the 
quantitative estimation of the bacterial numbers, at least 10 viewing fields per well 
were counted at 100x magnification. The total number of positive bacteria was 
calculated per sample, as previously described (Baumgartner, et al. 2012, Gmur & 
Thurnheer 2002). 
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Statistical analysis 
The differences in clinical parameters (patient age, implant age, bone loss, BOP, PI, 
PPD, keratinized mucosa) between the two diagnosis groups was statistically analysed 
by the Mann–Whitney test, except for gender and suppuration, which were analysed 
by the Chi-square test. The differences in bacterial numbers between the two 
diagnosis groups was also statistically analysed by the Mann–Whitney test, 
comparing the medians of the groups. The difference in prevalence of the studied taxa 
between the two clinical groups was analysed by the Chi-square test. The correlation 
between bacterial numbers and clinical parameters was investigated by Spearman 
correlation analysis. Differences were considered statistically significant at P < 0.05. 
 
Results 
Clinical and demographic characteristics of the subjects 
A total of 43 samples from sites/patients with peri-implantitis and 41 samples from 
sites/individuals with peri-implant health were collected. Clinical measurements for 
one individual with peri-implant health were not available, and hence were not 
included in the corresponding analyses (Table 2). There were no differences in age 
and gender distribution between the two clinical groups. When the clinical parameters 
were considered on the implant level, PPD, PI, BOP and bone loss were significantly 
higher in the peri-implantitis, than peri-implant health group. On the contrary, the 
width of the keratinized mucosa was significantly lower in peri-implantitis, compared 
to peri-implant health. Although, the difference in implant age between the two 
groups was marginally above significance levels (P = 0.055), this was numerically 
higher in peri-implantitis compared to peri-implant health by approximately 1.7 years. 
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Estimation of total bacterial numbers 
The total bacterial numbers were estimated using an oligonucleotide probe that 
identifies most oral eubacteria. Submucosal biofilm samples from sites with peri-
implantitis exhibited higher total bacterial counts (5.69x106 ± 1.32x107) compared to 
healthy sites (3.37x105 ± 1.36x106), a difference that proved to be highly statistically 
significant (P < 0.0001). 
 
Prevalence of Synergistetes and Spirochaetes in submucosal biofilm 
The prevalence of the various Synergistetes and Spirochaetes clusters was thereafter 
investigated (Table 3). Synergistetes cluster A was detected in 51.2 % of the healthy 
sites and 81.4 % of the sites with peri-implantitis, a difference that proved to be 
significant. When the sub-clusters A1 and A2 were considered, the former was 
detected in 41.4 % of healthy and 74.4 % of peri-implantitis sites, whereas the latter in 
48.7 % and 81.4 % of the sites, respectively. In both cases the difference was 
significant. In the case of Spirochaetes, Treponema cluster 1 (groups I-III) was 
detected in 17.0 % of healthy sites and 65.1 % of peri-implantitis sites, which proved 
to be significant. However, Treponema group IV was detected in only 2.4 % of the 
healthy, and 13.9 % of the peri-implantitis sites, an increase that was not significant. 
Hence, due to the low detection frequency and levels, no further statistical analysis 
was performed on the numbers of these bacterial taxa. 
 
Numbers of Synergistetes and Spirochaetes in submucosal biofilm 
The bacterial numbers of Synergistetes cluster A, their sub-clusters A1 and A2, as 
well as Treponema cluster 1 (groups I-III), in the submucosal biofilm samples were 
further evaluated. The data demonstrates that Synergistetes cluster A are found in 2.5-
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log higher numbers at sites with peri-implantitis, compared to healthy sites (Figure 
1A). Their distribution within Synergistetes sub-clusters A1 and A2 was further 
considered. Sub-clusters A1 and A2 were detected both at 2.8-log higher levels in 
peri-implantitis, compared to health (Figures 1B and 1C).  Finally, in the case of 
Treponema cluster 1 (groups I-III), their numbers in peri-implantitis were higher than 
in peri-implant health by approximately 2.4-log (Figure 1D). The differences between 
the two diagnosis groups proved to be significant for all studied bacterial taxa (P < 
0.0001). The median values, as well as lower and upper quartiles related to this Figure 
are provided in Table 4. 
 
Correlation of microbiological and clinical parameters 
Finally, the correlation between the bacterial numbers in submucosal biofilms and the 
clinical parameters of the corresponding sampled sites was investigated (Table 5). No 
correlation was found between implant age and the numbers of the different bacterial 
taxa in the biofilms. PPD positively correlated with the numbers of all studied taxa. PI 
correlated only with total bacterial numbers, but not with any of the specific taxa 
studied. BOP, bone loss and suppuration correlated with the numbers of Synergistetes 
cluster A and its sub-clusters, but not with Treponema cluster 1 (groups I-III) 
(correlation coefficients provided in Table 5). 
 
Discussion 
The present study investigated the prevalence and numbers of the bacterial phyla 
Synergistetes and Spirochaetes in submucosal biofilms from sites with peri-
implantitis, or peri-implant health. Whereas the association of Spirochaetes with peri-
implantitis has been established in earlier studies (Papaioannou, et al. 1995, Renvert, 
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et al. 2007), there has only been circumstantial evidence on the involvement of 
Synergistetes by sequencing approaches (Koyanagi, et al. 2010, Maruyama, et al. 
2014). Hence, this is the first study to use a targeted approach in order to investigate 
the involvement of this new phylum in peri-implantitis. Synergistetes cluster A was 
detected in half of the healthy sites, and its prevalence was significantly increased by 
a further 30% in peri-implantitis. Absolute bacterial numbers of this cluster in 
biofilms were also profoundly increased in peri-implantitis by 2.5-log, in relation to 
peri-implant health. These data show a strong association of Synergistetes cluster A 
with peri-implantitis, which is well in agreement with the elevated numbers of 
Synergistetes cluster A in periodontitis, compared to periodontal health (Belibasakis, 
et al. 2013), or in NUG, compared to plaque-induced gingivitis (Baumgartner, et al. 
2012).  
A recent study analysing the prevalence and microbial identity of biofilm 
samples from sites with peri-implantits by using a 16S rRNA gene clone library 
technique, supported that the phylum Synergistetes is, among other phyla, present 
only in peri-implantitis, and not in peri-implant health or periodontitis (Koyanagi, et 
al. 2010). A broad metagenomic approach has not been utilized in the present study, 
preventing the estimation of the relative role of Synergistetes within the whole 
microbial community. Nevertheless, the FISH method used here is a 16S rRNA-
targeted approach that enabled with high specificity the identification and 
quantification of viable Synergistetes in both peri-implant health and disease. It 
should also be noted that this clinical microbiological study is a retrospective one. 
Hence, a limitation in the interpretation of the findings is that they do not necessarily 
imply a cause-effect relationship between Synergistetes and peri-implantitis.  
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The Synergistetes sub-clusters A1 and A2 were further considered, and their 
numbers were found to be equally elevated in peri-implantitis, compared to peri-
implant health. In agreement with this finding, a similar increase of these two sub-
clusters has been earlier demonstrated in NUG, compared to plaque-induced gingivitis 
(Baumgartner, et al. 2012), which may imply that the distribution of Synergistetes A 
sub-clusters may not be crucial factor in the etiology of oral infectious disease. 
This study also investigated the association of Spirochaetes, represented by 
Treponema cluster 1 (groups I-III) and Treponema group IV, with peri-implantitis. 
Interestingly, the Treponema group IV was only rarely detected in peri-implantitis, or 
peri-implant health, and its prevalence did not significantly increase in the disease. In 
contrast, Treponema cluster 1 (groups I-III) was detected infrequently in peri-implant 
health, but its prevalence in peri-implantitis was significantly increased by almost 4-
fold. Its absolute numbers in the biofilms were accordingly increased by 2.4-log, 
indicating a strong association with peri-implantitis. The increased presence of 
Treponema cluster 1 (groups I-III), particularly Treponema denticola, in peri-
implantitis may not be a novel finding, as this has been already demonstrated by 
earlier works (Hultin, et al. 2002, Papaioannou, et al. 1995, Persson & Renvert 2014, 
Persson, et al. 2006, Renvert, et al. 2007, Shibli, et al. 2008). Accordingly, more 
recent metagenomic analysis document the broader presence of genera Treponema in 
peri-implantitis-associated biofilms (Koyanagi, et al. 2013, Koyanagi, et al. 2010, 
Kumar, et al. 2012, Maruyama, et al. 2014). The present study complements these 
earlier ones, by employing a 16S rRNA-targeted FISH method to identify and 
quantify their presence in peri-implantitis. Of note, while analysis of the microbial 
profiles according to smoking status was not performed here, this is an important 
factor to be considered, as smoking influences distinctively ecological succession in 
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biofilms and hence the composition of peri-implant microbiomes (Tsigarida, et al. 
2015). 
The association of clinical peri-implant parameters with the numbers of the 
studied taxa was further considered. The levels of Treponema cluster 1 (groups I-III) 
positively correlated with PPD, in line with earlier studies showing a correlation 
between increased levels of spirochetes and PPD in peri-implantitis (Papaioannou, et 
al. 1995, Renvert, et al. 2007). The present study failed, however, to disclose a 
significant correlation between Treponema cluster 1 (groups I-III) and any other 
clinical parameters, which may be at odds with a recent study showing the correlation 
of an uncultured Treponema sp. with several clinical peri-implant parameters 
(Maruyama, et al. 2014). As the methodological approach between the two studies is 
substantially different, it is difficult to compare the extent of overlap in the detected 
bacterial phylotypes. On the other hand, the levels of Synergistetes cluster A 
(including sub-clusters A1 and A2) in biofilms significantly correlated not only with 
PPD, but also with bone loss, suppuration and BOP, potentially indicating its stronger 
association with the severity of peri-implantitis, than Spirochaetes. 
In conclusion, the present study shows that Treponema cluster 1 (groups I-III) 
and Synergistetes cluster A are highly associated with peri-implantitis, as indicated by 
their increased prevalence and numbers in the disease. On the contrary Treponema 
group IV displays only little association, whereas there are no distinctive differences 
between the two Synergistetes A sub-clusters. Moreover, Synergistetes cluster A is 
more strongly associated with the severity peri-implantitis than Spirochaetes. 
Collectively, the clinical implication of this study is the demonstration that 
Synergistetes are involved in peri-implantitis and may constitute a more suitable 
microbiological indicator for disease diagnosis than Spirochaetes. 
14 
 
 
Acknowledgements 
The authors would like to thank Mrs. Helga Lüthi-Schaller for her excellent technical 
assistance. The study was funded by the authors’ Institute. 
 
References 
Amann, R. I., Ludwig, W. & Schleifer, K. H. (1995) Phylogenetic identification and 
in situ detection of individual microbial cells without cultivation. Microbiology 
Reviews 59: 143-169. 
Ammann, T. W., Bostanci, N., Belibasakis, G. N. & Thurnheer, T. (2013) Validation 
of a quantitative real-time pcr assay and comparison with fluorescence microscopy 
and selective agar plate counting for species-specific quantification of an in vitro 
subgingival biofilm model. Journal of Periodontal Research 48: 517-526. 
Baumgartner, A., Thurnheer, T., Luthi-Schaller, H., Gmur, R. & Belibasakis, G. N. 
(2012) The phylum synergistetes in gingivitis and necrotizing ulcerative gingivitis. 
Journal of Medical Microbiology 61: 1600-1609. 
Belibasakis, G. N. (2014) Microbiological and immuno-pathological aspects of peri-
implant diseases. Archives of Oral Biology 59: 66-72. 
Belibasakis, G. N., Charalampakis, G., Bostanci, N. & Stadlinger, B. (2015) Peri-
implant infections of oral biofilm etiology. Advances in Experimental Medicine and 
Biology 830: 69-84. 
Belibasakis, G. N., Ozturk, V. O., Emingil, G. & Bostanci, N. (2013) Synergistetes 
cluster a in saliva is associated with periodontitis. Journal of Periodontal Research 
48: 727-732. 
15 
 
Charalampakis, G. & Belibasakis, G. N. (2015) Microbiome of peri-implant 
infections: Lessons from conventional, molecular and metagenomic analyses. 
Virulence 6: 183-187. 
Choi, B. K., Wyss, C. & Gobel, U. B. (1996) Phylogenetic analysis of pathogen-
related oral spirochetes. Journal of Clinical Microbiology 34: 1922-1925. 
Dabdoub, S. M., Tsigarida, A. A. & Kumar, P. S. (2013) Patient-specific analysis of 
periodontal and peri-implant microbiomes. Journal of Dental Research 92: 168S-
175S. 
Dewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C., Yu, W. H., 
Lakshmanan, A. & Wade, W. G. (2010) The human oral microbiome. Jorunal of 
Bacteriology 192: 5002-5017. 
Dewhirst, F. E., Tamer, M. A., Ericson, R. E., Lau, C. N., Levanos, V. A., Boches, S. 
K., Galvin, J. L. & Paster, B. J. (2000) The diversity of periodontal spirochetes by 16s 
rrna analysis. Oral Microbiology and Immunology 15: 196-202. 
Drescher, J., Schlafer, S., Schaudinn, C., Riep, B., Neumann, K., Friedmann, A., 
Petrich, A., Gobel, U. B. & Moter, A. (2010) Molecular epidemiology and spatial 
distribution of selenomonas spp. In subgingival biofilms. European Journal of Oral 
Sciences 118: 466-474. 
Faveri, M., Figueiredo, L. C., Shibli, J. A., Perez-Chaparro, P. J. & Feres, M. (2015) 
Microbiological diversity of peri-implantitis biofilms. Advances in Experimental 
Medicine and Biology 830: 85-96. 
Fernandes Cdo, C., Rechenberg, D. K., Zehnder, M. & Belibasakis, G. N. (2014) 
Identification of synergistetes in endodontic infections. Microbial Pathogenesis 73: 1-
6. 
16 
 
Gmur, R., Guggenheim, B., Giertsen, E. & Thurnheer, T. (2000) Automated 
immunofluorescence for enumeration of selected taxa in supragingival dental plaque. 
European Jorunal of Oral Sciences 108: 393-402. 
Gmur, R. & Thurnheer, T. (2002) Direct quantitative differentiation between 
prevotella intermedia and prevotella nigrescens in clinical specimens. Microbiology 
148: 1379-1387. 
Guggenheim, B., Gmur, R., Galicia, J. C., Stathopoulou, P. G., Benakanakere, M. R., 
Meier, A., Thurnheer, T. & Kinane, D. F. (2009) In vitro modeling of host-parasite 
interactions: The 'subgingival' biofilm challenge of primary human epithelial cells. 
BMC Microbiology 9: 280. 
Haffajee, A. D., Teles, R. P. & Socransky, S. S. (2006) Association of eubacterium 
nodatum and treponema denticola with human periodontitis lesions. Oral 
Microbiology and Immunology 21: 269-282. 
Horz, H. P., Citron, D. M., Warren, Y. A., Goldstein, E. J. & Conrads, G. (2006) 
Synergistes group organisms of human origin. Journal of Clinical Microbiology 44: 
2914-2920. 
Hultin, M., Gustafsson, A., Hallstrom, H., Johansson, L. A., Ekfeldt, A. & Klinge, B. 
(2002) Microbiological findings and host response in patients with peri-implantitis. 
Clinical Oral Implants Research 13: 349-358. 
Koyanagi, T., Sakamoto, M., Takeuchi, Y., Maruyama, N., Ohkuma, M. & Izumi, Y. 
(2013) Comprehensive microbiological findings in peri-implantitis and periodontitis. 
Jorunal of Clinical Periodontology 40: 218-226. 
Koyanagi, T., Sakamoto, M., Takeuchi, Y., Ohkuma, M. & Izumi, Y. (2010) Analysis 
of microbiota associated with peri-implantitis using 16s rrna gene clone library. 
Journal of Oral Microbiology 2: doi: 10.3402/jom.v2i0.5104. 
17 
 
Kumar, P. S., Mason, M. R., Brooker, M. R. & O'Brien, K. (2012) Pyrosequencing 
reveals unique microbial signatures associated with healthy and failing dental 
implants. Journal of Clinical Periodontology 39: 425-433. 
Maruyama, N., Maruyama, F., Takeuchi, Y., Aikawa, C., Izumi, Y. & Nakagawa, I. 
(2014) Intraindividual variation in core microbiota in peri-implantitis and 
periodontitis. Scientific Reports 4: 6602. 
Mombelli, A. & Decaillet, F. (2011) The characteristics of biofilms in peri-implant 
disease. Journal of Clinical Periodontology 38 Suppl 11: 203-213. 
Moter, A., Hoenig, C., Choi, B. K., Riep, B. & Gobel, U. B. (1998) Molecular 
epidemiology of oral treponemes associated with periodontal disease. Journal of 
Clinical Microbiology 36: 1399-1403. 
Papaioannou, W., Quirynen, M., Nys, M. & van Steenberghe, D. (1995) The effect of 
periodontal parameters on the subgingival microbiota around implants. Clinical Oral 
Implants Research 6: 197-204. 
Persson, G. R. & Renvert, S. (2014) Cluster of bacteria associated with peri-
implantitis. Clinical Implant Dentistry and Related Research 16: 783-793. 
Persson, G. R., Salvi, G. E., Heitz-Mayfield, L. J. & Lang, N. P. (2006) Antimicrobial 
therapy using a local drug delivery system (arestin) in the treatment of peri-implantitis. 
I: Microbiological outcomes. Clinical Oral Implants Research 17: 386-393. 
Renvert, S., Roos-Jansaker, A. M., Lindahl, C., Renvert, H. & Rutger Persson, G. 
(2007) Infection at titanium implants with or without a clinical diagnosis of 
inflammation. Clinical Oral Implants Research 18: 509-516. 
Shibli, J. A., Melo, L., Ferrari, D. S., Figueiredo, L. C., Faveri, M. & Feres, M. (2008) 
Composition of supra- and subgingival biofilm of subjects with healthy and diseased 
implants. Clinical Oral Implants Research 19: 975-982. 
18 
 
Tsigarida, A.A., Dabdoub S.M., Nagaraja H.N. & Kumar, P.S. (2015) The influence 
of smoking on the peri-implant microbiome. Journal of Dental Research pii: 
0022034515590581 
Vartoukian, S. R., Palmer, R. M. & Wade, W. G. (2007) The division "synergistes". 
Anaerobe 13: 99-106. 
Vartoukian, S. R., Palmer, R. M. & Wade, W. G. (2009) Diversity and morphology of 
members of the phylum "synergistetes" in periodontal health and disease. Applied and 
Environmental Microbiology 75: 3777-3786. 
Wecke, J., Kersten, T., Madela, K., Moter, A., Gobel, U. B., Friedmann, A. & 
Bernimoulin, J. (2000) A novel technique for monitoring the development of bacterial 
biofilms in human periodontal pockets. FEMS Microbiology Letters 191: 95-101. 
You, M., Mo, S., Watt, R. M. & Leung, W. K. (2013) Prevalence and diversity of 
synergistetes taxa in periodontal health and disease. Journal of Periodontal Research 
48: 159-168. 
Zhuang, L. F., Watt, R. M., Mattheos, N., Si, M. S., Lai, H. C. & Lang, N. P. (2014) 
Periodontal and peri-implant microbiota in patients with healthy and inflamed 
periodontal and peri-implant tissues. Clinical Oral Implants Reseacrh doi: 
10.1111/clr.12508. 
Zijnge, V., van Leeuwen, M. B., Degener, J. E., Abbas, F., Thurnheer, T., Gmur, R. & 
Harmsen, H. J. (2010) Oral biofilm architecture on natural teeth. PLoS One 5: e9321. 
 
 
 
  
19 
 
Tables 
 
Table 1. 16 rRNA-targeted probe sequences, target taxa and validation references 
 
Probe    Sequence (5’–3’)   Target taxa 
EUB338-Cy3   GCTGCCTCCCGTAGGAGT Most eubacteria 
(Amman et al. 1995) 
SYN-A1409-FAM  ACACCCGGCTCGGGTGGT Synergistetes cluster A 
(Zijnge et al. 2010, Baumgartner et al. 2012) 
SYN-A1-632-FAM GCACCTCAGTCTCAACTGC Synergistetes cluster A1 
(Baumgartner et al. 2012) 
SYN-A2-207-Cy3  CCTCCTCCAGCGCATCTC Synergistetes cluster A2 
(Baumgartner et al. 2012) 
TrepG1-679-Cy3 GATTCCACCCCTACACTT Treponema groups I,II,III 
(Zijnge et al. 2010) 
Tlema738-Cy3  GCGTCAATTATCTGCCGG  Treponema group IV 
(Guggenheim et al. 2009)     
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Table 2. Patient demographic data and clinical parameters of the sampled implants 
 
Parameter   Health   Peri-implantitis P value 
Patient age (years + SD) 57.6 ± 15.1  59.1 ± 13.0  0.724 
Gender (M/F)   13/28   14/29   0.934 
Implant age (years + SD) 6.1 ± 4.5  7.8 ± 4.8  0.055 
Bone loss (mm)  0.02 ± 0.1  6.3 ± 2.6  <0.0001 * 
Suppuration (+/total) 0/40   22/43 (51.2 %) <0.0001* 
PPD (mm)   3.0 ± 0.4  6.8 ± 2.3  <0.0001 * 
BOP (% sites)   23 ± 28  79 ± 29  <0.0001 * 
PI (% sites)   15 ± 25  40 ± 37  0.002 * 
Keratinized mucosa (mm) 3.2 ± 1.5  1.9 ± 1.7  <0.0001 * 
 
For patient age and gender, n=41 for peri-implant health and n=43 for peri-
implantitis. For the remainder clinical measurements n=40 for peri-implant health and 
n=43 for peri-implantitis. * Statistically significant (P<0.05) difference between the 
two clinical diagnosis groups 
 
  
21 
 
Table 3. Prevalence of Synergistetes and Spriochaetes among subjects with peri-
implantitis and peri-implant health. 
 
Cluster/group   Health   Peri-implantitis P value 
Synergistetes A  21/41 (51.4 %) 35/43 (81.4 %) 0.003 * 
Synergistetes A1  17/41 (41.4 %) 32/43 (74.4 %) 0.002 * 
Synergistetes A2  20/41 (48.7 %) 35/43 (81.4 %) 0.001 * 
Treponema cluster 1  7/41 (17.0 %)  28/43 (65.1 %) < 0.001 * 
Treponema group IV  1/41 (2.4 %)  6/43 (13.9 %)  0.056 
 
* Statistically significant (P<0.05) difference between the two clinical diagnosis 
groups. 
 
 
Table 4. Median and (lower/upper) quartile values of Synergistetes and Spriochaetes 
in the peri-implantitis and peri-implant health groups 
 
Cluster/group   Health    Peri-implantitis 
Synergistetes A  50 (25/250)   2.6x103 (250/4.4x104) 
Synergistetes A1  25 (25/130)   300 (25/2.3x104) 
Synergistetes A2  25 (25/100)   400 (50/1.8x104) 
Treponema cluster 1  25 (25/25)   250 (25/1x104) 
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Table 5. Correlation between bacterial numbers in submucosal biofilms and clinical 
parameters of the samples sites. 
 
Parameter Total   SynA  SynA1  SynA2  Trep1  
PPD  0.39 *  0.53 *  0.51 *  0.58 *  0.34 * 
BOP  0.20  0.39 *  0.35 *  0.39 *  0.24 
PI  0.25 *  0.23  0.12  0.07  0.14 
Suppuration 0.23 *  0.43 *  0.33 *  0.49 *  0.06 
Implant wear 0.05  0.20  0.27  0.15  0.20 
Bone loss 0.45 *  0.62 *  0.47 *  0.53 *  0.34 
 
The Spearman’s r correlation coefficient is provided. * Statistically significant 
correlation (P < 0.05). Total; total bacterial numbers, SynA; Synergistetes cluster A, 
SynA1; Synergistetes sub-cluster A1, SynA2; Synergistetes sub-cluster A2, Trep1; 
Treponema cluster 1 (groups I-III). 
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Figure legends 
 
 
 
 
Figure 1. Numbers of Synergistetes cluster A (A), Synergistetes sub-cluster A1 (B), 
Synergistetes sub-cluster A2 (C), and Treponema cluster 1 (groups I-III) (D) in 
submucosal biofilms of patients with peri-implantitis (n=43) and peri-implant health 
(n=41). The numbers represent the positive bacterial counts by FISH, per sample. The 
differences between all pair-wise comparisons proved to be statistically significant 
(P<0.05). 
